Session 1296: Novel Therapies, Part 2

Cochair(s): WT Beck, H de The
Date: Tue 12 February 2002, Time: 14:00 - 16:00
Location: Amphithéâtre Monod

Oral Presentations

Time Number Title / Authors / Affiliations
14:00 494 Tumor treatment by a new system for focalized therapy assessed on an animal model
EMH Hiltbrand, G Quash, H Fessi, F Buchegger, T Binzoni, J Belenger, M Costa, J Foray, H Mehier
1Univ. hospital Geneva, Geneva, Geneva Switzerland, 2University Hospital, Lyon-Sud, France, 3LAGEP Lyon-1, France, , 4CERMA Archamps, France
14:15 495 Detection of therapeutical effects by anti-EGFR therapy alone and in combination with chemotherapeutics against human squamous cell carcinomas of the head and neck using microarray techniques
MH Hambek
University of Frankfurt Medical School, Frankfurt / Main, Hessen Germany
14:30 496 Potential role of extracorporeal photochemotherapy in antineoplastic treatment
U Prati, C Perotti, L Roveda, F Trotta, P Valsecchi, D Roberto, C Rossella, C Zonta, A Clerici, C Ferrari, GL Viarengo, S Bernuzzi, D Fante, L Salvaneschi
1Chirurgia Sperimentale e Tecnologie Chirurgiche Innovative, Policlinico San Matteo, Pavia, PV Italy, 2Chirurgia Epatopancreatica, Policlinico San Matteo, Pavia, PV Italy, 3Dipartimento di Chirurgia, Universita' degli Studi di Pavia, Italy, Pavia, 4Servizio di Immunoematologia e Trasfusione, Policlinico San Matteo, Pavia, PV Italy
14:45 497 Expression of EAG potasssium channels in tumor tissue
MD LA Pardo, B Hemmerlein, A Sánchez, HJ Radzun, W Stühmer
1iOnGen AG, Goettingen, Germany, 2Max-Planck-Insitute for Experimental Medicine, Göttingen, Germany, 3Department of Pathology, University Hospital Göttingen, Germany
15:00 498 Expression and regulation of the Coxsackie- and Adenovirus Receptor (CAR) in premalignant lesions and advanced neoplasms.
M Anders, C Christian, RS Warren, A Balmain, MJ Bissell, WM Korn
1Comprehensive Cancer Center, San Francisco, CA and, 2Department of Surgery, 3Division of Gastroenterology; University of California San Francisco, San Francisco, CA and, 4Lawrence Berkeley National Laboratory, Berkeley, United States
15:15 499 *Survival of colorectal cancer patients with high levels of sialyl lewis-x and sialyl lewis-a epitope expression on tumor cells was improved by cimetidine
SM Matsumoto
Fujita Health University, Second Teaching Hospital, Nagoya, Aichi Japan
15:30 500 Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
AN Garratt, B Erdmann, B Pilz, N Wettschureck, S Britsch, N Huebner, KR Chien, C Birchmeier
1Max-Delbrueck-Center for Molecular Medicine, Germany, CA, 2Franz-Volhard-Klinik, Germany, CA, 3University of Heidelberg, Germany, CA, 4University of California San Diego, Medical School, La Jolla, USA
15:45 501 Recombinant adenovirus AdTIMP-2 inhibits tumor growth, angiogenesis and metastasis, and prolongs survival in mice
H Li, F Lidenmeyer, C Grenet, P Opolon, S Menashi, C Soria, P Yeh, M Perricaudet, H Lu
CNRS UMR 1582, Institut Gustave Roussy, Rue C. Desmoulins Villejuif, France